121 related articles for article (PubMed ID: 7082353)
1. Stimulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by o,p'-DDD.
Stacpoole PW; Varnado CE; Island DP
Biochem Pharmacol; 1982 Mar; 31(5):857-60. PubMed ID: 7082353
[TBL] [Abstract][Full Text] [Related]
2. Effects of cortisol or corticotropin administration on hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity and plasma lipids in the pregnant rat and fetuses.
Innis SM; Haave NC
J Dev Physiol; 1989 Jun; 11(6):346-50. PubMed ID: 2556470
[TBL] [Abstract][Full Text] [Related]
3. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells.
Hermansson V; Asp V; Bergman A; Bergström U; Brandt I
Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473
[TBL] [Abstract][Full Text] [Related]
4. Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers.
Cai W; Benitez R; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL
Biochem Pharmacol; 1995 May; 49(10):1483-9. PubMed ID: 7763292
[TBL] [Abstract][Full Text] [Related]
5. [The effects of o,p'-DDD on adrenal steroidogenesis and hepatic steroid metabolism].
Ojima M; Saitoh M; Itoh N; Kusano Y; Fukuchi S; Naganuma H
Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):168-78. PubMed ID: 3874792
[TBL] [Abstract][Full Text] [Related]
6. Effects of aging on cholesterol content and cholesterol-metabolizing enzymes in the rat adrenal gland.
Popplewell PY; Azhar S
Endocrinology; 1987 Jul; 121(1):64-73. PubMed ID: 2885178
[TBL] [Abstract][Full Text] [Related]
7. Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals.
Moore RN; Penney DP; Averill KT
Anat Rec; 1980 Sep; 198(1):113-24. PubMed ID: 7457928
[TBL] [Abstract][Full Text] [Related]
8. [Effect of O,N'=dichlorodiphenyldichloroethane and pertan in vitro on glutathione reductase activity in the adrenals of dogs and guinea pigs].
Komissarenko VP; Chelnakova IS; Mikosha AS
Biull Eksp Biol Med; 1978 Feb; 85(2):159-61. PubMed ID: 630087
[TBL] [Abstract][Full Text] [Related]
9. The organochlorine o,p'-DDD disrupts the adrenal steroidogenic signaling pathway in rainbow trout (Oncorhynchus mykiss).
Lacroix M; Hontela A
Toxicol Appl Pharmacol; 2003 Aug; 190(3):197-205. PubMed ID: 12902190
[TBL] [Abstract][Full Text] [Related]
10. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
[TBL] [Abstract][Full Text] [Related]
11. In vitro macromolecular binding of 2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD) in the mouse lung and liver.
Lund BO; Bergman A; Brandt I
Chem Biol Interact; 1989; 70(1-2):63-72. PubMed ID: 2736677
[TBL] [Abstract][Full Text] [Related]
12. The effect of o,p'-DDD on adrenal steroid replacement therapy requirements.
Robinson BG; Hales IB; Henniker AJ; Ho K; Luttrell BM; Smee IR; Stiel JN
Clin Endocrinol (Oxf); 1987 Oct; 27(4):437-44. PubMed ID: 2830062
[TBL] [Abstract][Full Text] [Related]
13. Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity.
Stacpoole PW; Harwood HJ; Varnado CE
J Clin Invest; 1983 Nov; 72(5):1575-85. PubMed ID: 6630519
[TBL] [Abstract][Full Text] [Related]
14. [Activity of glutathione reductase in the adrenal glands and the liver of dogs after administration O,P-DDD, perthane and ACTH].
Komissarenko VP; Chelnakova IS; Mikosha AS
Probl Endokrinol (Mosk); 1978; 24(1):95-8. PubMed ID: 204922
[TBL] [Abstract][Full Text] [Related]
15. Loss of capacity to elevate plasma cortisol in rainbow trout (Oncorhynchus mykiss) treated with a single injection of o,p'-dichlorodiphenyldichloroethane.
Benguira S; Leblond VS; Weber JP; Hontela A
Environ Toxicol Chem; 2002 Aug; 21(8):1753-6. PubMed ID: 12152779
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 1-(0-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p'-DDD) in rats.
Reif VD; Sinsheimer JE
Drug Metab Dispos; 1975; 3(1):15-25. PubMed ID: 234830
[TBL] [Abstract][Full Text] [Related]
17. o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement.
Hogan TF; Citrin DL; Johnson BM; Nakamura S; Davis TE; Borden EC
Cancer; 1978 Nov; 42(5):2177-81. PubMed ID: 719602
[TBL] [Abstract][Full Text] [Related]
18. Dietary carbohydrate decreases 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in rat liver.
Stacpoole PW; Harwood HJ; Varnado CE
Biochem Biophys Res Commun; 1983 Jun; 113(3):888-94. PubMed ID: 6870899
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs.
Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I
Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626
[TBL] [Abstract][Full Text] [Related]
20. [Changes in mitochondrial and microsomal electron transport as affected by o,p'-dichlorodiphenyldichloroethane].
Komissarenko VP; Mikosha AS; Chelnakova IS
Ukr Biokhim Zh (1978); 1981; 53(6):74-7. PubMed ID: 6798728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
